Fosun International Limited

Fosun International Limited operates in health, happiness, wealth, and intelligent manufacturing sectors in Mainland China, Portugal, and internationally. It operates in five segments: Health, Happiness, Insurance, Asset Management, and Intelligent Manufacturing. The Health segment engages in the research, development, manufacture, sale, and trading of pharmaceutical, biopharmaceutical, and health products; and provision of medical and health management services. The Happiness segment operates and invests in tourism and leisure, fashion consumer, and lifestyle industries. The Insurance segment operates and invests in the insurance markets. The Asset Management segment engages in the asset management and market investments activities. The Intelligent Manufacturing segment operates and invests in the intelligent manufacturing business; and produces iron and steel ore. It is also involved in the capital investment and management, property development, retail, and reinsurance business; manufacture and sale of iron and steel products; provision of banking and financial, and medical consultation services, as well as digital solutions. The company was founded in 1992 and is based in Shanghai, China. Fosun International Limited is a subsidiary of Fosun Holdings Limited.

Fosun International Limited trades as FOSUY on OTC. The company is classified in Industrials / Conglomerates and reports in USD.

The current profile places the business in Conglomerates. This section is intended to summarize the operating segments, products, geographies, and main revenue lines from official filings.

Detailed operating-segment data is not available for this symbol yet.

Use this area for management strategy, capital allocation priorities, target markets, and measurable goals from the latest annual report or investor presentation.

The app now provides the structure, but exact strategic claims should come from official company documents before being treated as a finished investment thesis.

Fosun International Limited can be compared against peers such as Aker ASA, Ayala Corporation, Ayala Corporation, The Bidvest Group Limited, The Bidvest Group Limited, China Railway Signal & Communication Corporation Limited.

A complete thesis should compare growth, margins, balance-sheet risk, valuation multiples, and market position against direct competitors.

Current signals to investigate include market capitalization of $3.86B, beta of 0.46, and return on equity of N/A.

This section should be validated with evidence such as durable margins, brand strength, regulation, switching costs, cost advantage, distribution, or technology.

Key risks should include financial leverage, cyclicality, customer concentration, regulatory exposure, currency risk, and execution risk.

FOSUY currently shows total debt of N/A and beta of 0.46. Missing data should be treated as a research gap, not as low risk.

Production-capacity detail is not available as structured data yet. For industrial, defense, semiconductor, or real-estate companies, this should be reviewed from annual reports and investor presentations.

No structured backlog field is available yet. If the company reports backlog, review the relevant filing section before adding it to the thesis.

Use this section for major contracts, product launches, construction projects, acquisitions, or strategic programs that can materially affect valuation.

No recent SEC-style filings are available for this symbol yet.

Customer concentration is not available as structured data here. Add it from official filings when a company discloses material customers or revenue concentration.

Supplier concentration and critical supply-chain dependencies are not available as structured data here. This should be researched from annual reports and risk disclosures.

Company website: https://www.fosun.com

For US-listed stocks, verify the thesis against official filings, earnings call transcripts, and company investor relations materials.